Ask an Expert is a free question-and-answer service about breast cancer and breast health that is available on weekends. If you'd like to ask a question or comment, please visit us again on Saturday or Sunday. In the meantime, please search the existing topics using the search tool at the top of the page. It's quite possible that one of our many existing topics already addresses your question.
If you would like a consultation with a breast specialist at the Johns Hopkins Avon Foundation Breast Center, call 443-778-2778. It is possible to get an appointment for a second opinion within a few days of contacting us.
We hope you find the information helpful!
|Forum||Questions||Ask a Question|
Questions about Hormonal Therapy.
|Asked||Publicly Submitted Question|
|2/13/2006||My friend is 55 years old and was diagnosed with inflammatory breast cancer in her left breast 10 years ago. She was treated successfully (mastectomy, followed by a bone marrow transplant and radiation) and has until last month been cancer free. However, a recent mammogram of her right breast revealed a 1 1/4" tumor. The biopsy showed that it is HER2 negative, it is estrogen and progesterone receptor positive, and it is not inflammatory. She is about to have a mastectomy of her right breast (surgery is tomorrow) and we will then know how many nodes are involved, etc. Her ongologist has recommended Taxol, followed most likely by radiation. He also recommends that she takes an aromotase inhibitor (Arimidex) for the next 5 years since she is post-menopausal. Our question is: Since both breasts have been removed, why does she still need to take the aromotase inhibitor? We thought that the aromotase inhibitor will mainly prevent a reoccurance of cancer in the breast. Are there other places in the body an estrogen receptor positive cancer can occur, and if so, where would those be? What is the probability of such an occurance? Are there any alternatives to taking the aromotase inhibitor that could have less side effects?|
|Replied||JHU's Breast Center Reply|
|2/14/2006||its for local recurrence in the remaining breast tissue (some tissue still remains after a mastectomy) and also for prevention of distant recurrence. her body still produces estrogen from the adrenal glands... and the distant mets would happen possibly in the liver, bone or lungs.|
Please note: This service is not intended to provide primary medical advice concerning specific medical care or treatment. Ask an Expert is a free service operated by health care professionals at the Johns Hopkins Avon Foundation Breast Center. Due to the volume of questions and their complexity, there are times when medical oncologists, surgeons, radiation oncologists or oncology nurses are consulted for their input. These individuals volunteer their time for this service and will respond as soon as they are able. Please do not post or send the same question to us in multiple locations or categories.